CSB

Stanford School of Medicine

Chemical & Systems Biology

 
 

Cardioprotective mechanisms of PKC isozyme-selective activators and inhibitors in the treatment of ischemia-reperfusion injury.

Posted by CSB Department on June 1, 2007

Budas GR, Churchill EN, Mochly-Rosen D. (2007) Pharmacol. Res. 55(6):523-36 [PubMed]